Growth differentiation factor 15 and coronary collateral formation

Clinical Cardiology

Volumn 33, Issue 1, 2010, Pages

  Sun, Tao ^a,b   Huang, Yanbo ^a   Phillips, M Ian ^b   Luo, Xinping ^a   Zhu, Jun ^a   Shi, Haiming ^a   Li, Jian ^a  

^a FUDAN UNIVERSITY   (China)

^b KECK GRADUATE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH DIFFERENTIATION FACTOR 15; N(G),N(G) DIMETHYLARGININE; VASCULOTROPIN RECEPTOR 1;

ADULT; AGED; AMINO ACID BLOOD LEVEL; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY COLLATERAL CIRCULATION; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; SCORING SYSTEM;

AGED; ANALYSIS OF VARIANCE; ARGININE; COLLATERAL CIRCULATION; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY CIRCULATION; CORONARY STENOSIS; CROSS-SECTIONAL STUDIES; FEMALE; GROWTH DIFFERENTIATION FACTOR 15; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; STATISTICS, NONPARAMETRIC; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 74949129224     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.20698     Document Type: Article

References (20)

1. Pohl T, Seiler C, Billinger M, et al. Frequency distribution of collateral flow and factors influencing collateral channel development. Functional collateral channel measurement in 450 patientswith coronary artery disease. J Am Coll Cardiol. 2001;38(7):1872-1878.
2. Altin T, Kilickap M, Tutar E, et al. The relationship of chronic angiotensin converting enzyme inhibitor use and coronary collateral vessel development. Int Heart J. 2007;48(4):435-442.
3. Dincer I, Ongun A, Turhan S, et al. Association between the dosage and duration of statin treatment with coronary collateral development. Coron Artery Dis. 2006;17(6):561-565.
4. Ikeuchi M, Tsutsui H, Shiomi T, et al. Inhibition of TGF-β signaling exacerbates early cardiac dysfunction but prevents late remodeling after infarction. Cardiovasc Res. 2004;64(3):526-535.
5. Kempf T, Eden M, Strelau J, et al. The transforming growth factor-β superfamily member growth-differentiation factor-15 protects the heart from ischemia/reperfusion injury. Circ Res. 2006;98(3):351-360.
6. Xu J, Kimball TR, Lorenz JN, et al. GDF15/MIC-1 functions as a protective and antihypertrophic factor released from the myocardium in association with SMAD protein activation. Circ Res. 2006;98(3):342-350.
7. Brown DA, Breit SN, Buring J, et al. Concentration in plasma of macrophage inhibitory cytokine-1 and risk of cardiovascular events in women: a nested case-control study. Lancet. 2002;359(9324):2159-2163.
8. Kempf T, Björklund E, Olofsson S, et al. Growth-differentiation factor-15 improves risk stratification in ST-segment elevation myocardial infarction. Eur Heart J. 2007;28(23):2858-2865.
9. Wollert KC, Kempf T, Peter T, et al. Prognostic value of growth differentiation factor-15 in patients with non-ST-elevation acute coronary syndrome. Circulation. 2007;115(8):962-971.
10. Eggers KM, Kempf T, Allhoff T, et al. Growth-differentiation factor-15 for early risk stratification in patients with acute chest pain. Eur Heart J. 2008;29(19):2327-2335.
11. Jacobi J, Sydow K, von Degenfeld G, et al. Overexpression of dimethylarginine dimethylaminohydrolase reduces tissue asymmetric dimethylarginine levels and enhances angiogenesis. Circulation. 2005;111(11):1431-1438.
12. Henry TD, Annex BH, McKendall GR, et al. The VIVA trial: Vascular Endothelial Growth Factor in Ischemia for Vascular Angiogenesis. Circulation. 2003;107(10):1359-1365.
13. Lähteenvuo JE, Lähteenvuo MT, Kivelä A, et al. Vascular endothelial growth factor-β induces myocardium-specific angiogenesis and arteriogenesis via vascular endothelial growth factor receptor-1- and neuropilin receptor-1-dependent mechanisms. Circulation. 2009;119(6):845-856.
14. Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol. 1983;51(3):606.
15. Rentrop KP, Cohen M, Blanke H, et al. Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects. J Am Coll Cardiol. 1985;5(3):587-592.
16. Sherman JA, Hall A, Malenka DJ, et al. Humoral and cellular factors responsible for coronary collateral formation. Am J Cardiol. 2006;98(9):1194-1197.
17. Kocaman SA, Sahinarslan A, Biberoglu G, et al. Asymmetric dimethylarginine and coronary collateral vessel development. Coron Artery Dis. 2008;19(7):469-474.
18. Wollert KC, Kempf T, Lagerqvist B, et al. Growth differentiation factor 15 for risk stratification and selection of an invasive treatment strategy in non ST-elevation acute coronary syndrome. Circulation. 2007;116(14):1540-1548.
19. Kempf T, Björklund E, Olofsson S, et al. Growth-differentiation factor-15 improves risk stratification in ST-segment elevation myocardial infarction. Eur Heart J. 2007;28(23):2858-2865.
20. Eggers KM, Kempf T, Allhoff T, et al. Growth-differentiation factor-15 for early risk stratification in patients with acute chest pain. Eur Heart J. 2008;29(19):2327-2335.